Literature DB >> 221905

Accelerated clearance of low-density and high-density lipoproteins and retarded clearance of E apoprotein-containing lipoproteins from the plasma of rats after modification of lysine residues.

R W Mahley, K H Weisgraber, T L Innerarity, H G Windmueller.   

Abstract

Selective chemical modification of lysine residues of lipoproteins by acetoacetylation dramatically altered the metabolism of the lipoproteins without significantly altering other physical or chemical properties. Modification of 30-60% of the total lysine residues of iodinated rat or human low-density lipoproteins ((125)I-LDL) resulted in a rapid removal of these acetoacetylated lipoproteins from the plasma of rats. Within minutes after intravenous injection into intact rats, greater than 80% of the total injected dose disappeared from the plasma. The rapidly cleared acetoacetylated LDL appeared in the liver, and within 6-30 min as much as 50-80% of the total injected dose of modified LDL could be accounted for in the liver. Furthermore, it was possible to demonstrate in the isolated perfused rat liver that the Kupffer cells were responsible for the lipoprotein uptake. Human high-density lipoproteins (HDL(3)) were also rapidly removed from the plasma after acetoacetylation. In striking contrast, acetoacetylation (30-60%) of two E apoprotein-containing lipoproteins (rat HDL(1) and dog HDL(c)) retarded their removal from the plasma. The accelerated removal of modified LDL and HDL(3), in contrast to the retarded removal of modified HDL(1) and HDL(c), suggests that the recognition and removal process is specific for a property acquired by only certain lipoproteins after acetoacetylation. Moreover, these results suggest that lysine residues of the E apoprotein may play a functional role in the recognition process for the normal clearance of HDL(1) and HDL(c), a process that is interfered with after acetoacetylation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 221905      PMCID: PMC383467          DOI: 10.1073/pnas.76.4.1746

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  10 in total

1.  Apoprotein (E--A-II) complex of human plasma lipoproteins. II. Receptor binding activity of a high density lipoprotein subfraction modulated by the apo(E--A-II) complex.

Authors:  T L Innerarity; R W Mahley; K H Weisgraber; T P Bersot
Journal:  J Biol Chem       Date:  1978-09-10       Impact factor: 5.157

2.  Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts.

Authors:  K H Weisgraber; T L Innerarity; R W Mahley
Journal:  J Biol Chem       Date:  1978-12-25       Impact factor: 5.157

3.  Inhibition of lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in arginine-rich and B apoproteins.

Authors:  R W Mahley; T L Innerarity; R E Pitas; K H Weisgraber; J H Brown; E Gross
Journal:  J Biol Chem       Date:  1977-10-25       Impact factor: 5.157

4.  The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations.

Authors:  D W Bilheimer; S Eisenberg; R I Levy
Journal:  Biochim Biophys Acta       Date:  1972-02-21

5.  The binding of desialylated glycoproteins by plasma membranes of rat liver.

Authors:  W E Pricer; G Ashwell
Journal:  J Biol Chem       Date:  1971-08-10       Impact factor: 5.157

6.  Determination of free amino groups in proteins by trinitrobenzenesulfonic acid.

Authors:  A F Habeeb
Journal:  Anal Biochem       Date:  1966-03       Impact factor: 3.365

7.  The rat arginine-rich apoprotein and its redistribution following injection of iodinated lipoproteins into normal and hypercholesterolemic rats.

Authors:  K H Weisgraber; R W Mahley; G Assmann
Journal:  Atherosclerosis       Date:  1977-10       Impact factor: 5.162

8.  Canine hyperlipoproteinemia and atherosclerosis. Accumulation of lipid by aortic medial cells in vivo and in vitro.

Authors:  R W Mahley; T L Innerarity; K H Weisgraber; D L Fry
Journal:  Am J Pathol       Date:  1977-04       Impact factor: 4.307

9.  Metabolic fate of rat and human lipoprotein apoproteins in the rat.

Authors:  S Eisenberg; H G Windmueller; R I Levy
Journal:  J Lipid Res       Date:  1973-07       Impact factor: 5.922

10.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

Authors:  A E Bolton; W M Hunter
Journal:  Biochem J       Date:  1973-07       Impact factor: 3.857

  10 in total
  13 in total

1.  Purification and characterization of a bovine acetyl low density lipoprotein receptor.

Authors:  T Kodama; P Reddy; C Kishimoto; M Krieger
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

2.  Control of simian virus 40 gene expression at the levels of RNA synthesis and processing: thermally induced changes in the ratio of the simian virus 40 early mRNA's and proteins.

Authors:  J C Alwine; G Khoury
Journal:  J Virol       Date:  1980-07       Impact factor: 5.103

3.  Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe.

Authors:  Ryan E Temel; Weiqing Tang; Yinyan Ma; Lawrence L Rudel; Mark C Willingham; Yiannis A Ioannou; Joanna P Davies; Lisa-Mari Nilsson; Liqing Yu
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

4.  In situ labelling of vascular endothelium with fluorescent acetylated low density lipoprotein.

Authors:  P A Netland; B R Zetter; D P Via; J C Voyta
Journal:  Histochem J       Date:  1985-12

5.  Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins.

Authors:  M E Haberland; A M Fogelman; P A Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

6.  Impaired receptor-mediated catabolism of low density lipoprotein in the WHHL rabbit, an animal model of familial hypercholesterolemia.

Authors:  D W Bilheimer; Y Watanabe; T Kita
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

7.  Dominant negative mutations of the scavenger receptor. Native receptor inactivation by expression of truncated variants.

Authors:  S Dejager; M Mietus-Snyder; A Friera; R E Pitas
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

8.  Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages.

Authors:  A M Fogelman; I Shechter; J Seager; M Hokom; J S Child; P A Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

9.  Inhibition of receptor-mediated clearance of lysine and arginine-modified lipoproteins from the plasma of rats and monkeys.

Authors:  R W Mahley; K H Weisgraber; G W Melchior; T L Innerarity; K S Holcombe
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

10.  Altered hepatic catabolism of low-density lipoprotein subjected to lipid peroxidation in vitro.

Authors:  W L Stone; M Heimberg; R L Scott; I LeClair; H G Wilcox
Journal:  Biochem J       Date:  1994-02-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.